A platform company
Linking pharmaceutical innovation and
commercialization with strong product
lifecycle management capability
commercialization with strong product
lifecycle management capability
Focusing on unmet clinical needs, we collaborate with global biotech/biopharma to jointly develop first- or best-in-class innovative products.
Adhering to the patient-centered philosophy, we are dedicated to providing competitive products and services that enable the more effective diagnosis and treatment, whilst enhancing clinical practice to the ultimate benefit of the patient.
On November 25, 2023, the “Innovative Medicine Brings Brighter Future of Skin Health – 2023 Frontiers Conference on New Developments of Dermatological Treatment” was grandly held in Sanya, Hainan Province. The conference was co-organized by Hainan Lecheng Real World Research Institute and Hainan Boao Lecheng International Medical Tourism Pioneer Zone Administration. It brought together many top domestic scholars and clinical experts in the dermatology field to share in-depth research on the pathogenesis, diagnosis and treatment of psoriasis and vitiligo, providing more new technologies and therapies for the clinical treatment of the related diseases. The innovative drug for psoriasis treatment, ILUMETRI (Tildrakizumab Injection) made its debut at the conference, demonstrating CMS’s ability to empower the continuous transformation of innovative outcomes into diagnosis and therapeutic practice. Gathering leading academic forces Exchanging new developments in dermatological treatment More than 200 medical experts in the field of psoriasis and vitiligo […]
We collaborate with global innovative companies in flexible structures to jointly build a pharmaceutical ecosystem in a sustainable and collaborative setting for the benefit of all stakeholders.
If you are interested in joining us, or curious about our business and products, please feel free to contact us.